Trial Profile
Phase II Study Evaluating the Effectiveness of the Exemestane (Aromasin) With Tamoxifen on the Rate of Clinical Response Menopausal in Patients With Locally Advanced Breast Tumors.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Exemestane (Primary) ; Tamoxifen (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms TAMARO
- 23 Jun 2009 New trial record